RA Capital Management - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q3 2023$5,725,631
-27.5%
6,991,0030.0%0.11%
-24.2%
Q2 2023$7,899,833
+13.0%
6,991,0030.0%0.15%
-5.7%
Q1 2023$6,990,304
+15.2%
6,991,0030.0%0.16%
+28.5%
Q4 2022$6,066,792
-32.7%
6,991,0030.0%0.12%
-35.9%
Q3 2022$9,018,000
+48.3%
6,991,0030.0%0.19%
+18.5%
Q2 2022$6,082,000
-71.2%
6,991,0030.0%0.16%
-64.9%
Q1 2022$21,113,000
-41.4%
6,991,0030.0%0.46%
-27.4%
Q4 2021$36,004,000
-78.7%
6,991,0030.0%0.64%
-72.9%
Q3 2021$169,392,000
+24.1%
6,991,0030.0%2.35%
+7.1%
Q2 2021$136,534,000
+146.7%
6,991,003
+133.7%
2.19%
+162.7%
Q1 2021$55,337,0002,991,2080.83%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$520,0000.20%
Kynam Capital Management, LP 739,649$643,0000.16%
RA Capital Management 6,991,003$6,082,0000.16%
Ikarian Capital, LLC 677,859$591,0000.11%
DAFNA Capital Management LLC 250,000$218,0000.06%
UBS OCONNOR LLC 651,506$567,000,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,677,519$1,459,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 77,851$68,0000.00%
CSS LLC/IL 20,000$17,0000.00%
Virtu Financial LLC 16,658$14,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders